Venous thromboembolism prevention in the acutely ill medical patient: A review of the literature and focus on special patient populations

被引:12
作者
Pendleton, R
Wheeler, M
Rodgers, G
机构
[1] Univ Utah, Med Ctr, Div Gen Internal Med, Dept Internal Med, Salt Lake City, UT 84132 USA
[2] Univ Utah, Dept Pharm, Salt Lake City, UT 84132 USA
关键词
thromboembolism/epidemiology; thromboembolism/prevention; control anticoagulants;
D O I
10.1002/ajh.20360
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although venous thromboembolism (VTE) is a major public health problem, until recently, our understanding of the risk of VTE in hospitalized acutely ill medical patients has been incomplete. Fortunately, over the past 5 years, there has been an increasing body of literature that highlights the risk of VTE in the nonsurgical patient, identifies unique patient-risk factors, and defines adequate preventative measures. This review highlights the current literature with regard to epidemiology of VTE in hospitalized medical patients and the risk-stratification of these patients and deals with optimal preventative regimens and prevention strategies in special patient groups. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:229 / 237
页数:9
相关论文
共 75 条
[1]   Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies [J].
Ahmad, S ;
Jeske, WP ;
Walenga, JM ;
Hoppensteadt, DA ;
Wood, JJ ;
Herbert, JM ;
Messmore, HL ;
Fareed, J .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1999, 5 (04) :259-266
[2]   Venous thrombosis associated with the placement of peripherally inserted central catheters [J].
Allen, AW ;
Megargell, JL ;
Lynch, FC ;
Singh, H ;
Singh, Y ;
Waybill, PN .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2000, 11 (10) :1309-1314
[3]   Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia [J].
Amiral, J ;
Lormeau, JC ;
MarfaingKoka, A ;
Vissac, AM ;
Wolf, M ;
BoyerNeumann, C ;
Tardy, B ;
Herbert, JM ;
Meyer, D .
BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 (02) :114-117
[4]   THE PREVALENCE OF RISK-FACTORS FOR VENOUS THROMBOEMBOLISM AMONG HOSPITAL PATIENTS [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
FORCIER, A .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (08) :1660-1664
[5]  
Anderson FA, 2003, BLOOD, V102, p319A
[6]   A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
PATWARDHAN, NA ;
JOVANOVIC, B ;
FORCIER, A ;
DALEN, JE .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) :933-938
[7]   CHANGING CLINICAL-PRACTICE - PROSPECTIVE-STUDY OF THE IMPACT OF CONTINUING MEDICAL-EDUCATION AND QUALITY ASSURANCE PROGRAMS ON USE OF PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
FORCIER, A ;
PATWARDHAN, NA .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (06) :669-677
[8]   PHYSICIAN PRACTICES IN THE PREVENTION OF VENOUS THROMBOEMBOLISM [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
FORCIER, A ;
PATWARDHAN, NA .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) :591-595
[9]   VENOUS THROMBOEMBOLIC COMPLICATIONS (VTE) IN CHILDREN - FIRST ANALYSES OF THE CANADIAN REGISTRY OF VTE [J].
ANDREW, M ;
DAVID, M ;
ADAMS, M ;
ALI, K ;
ANDERSON, R ;
BARNARD, D ;
BERNSTEIN, M ;
BRISSON, L ;
CAIRNEY, B ;
DESAI, D ;
GRANT, R ;
ISRAELS, S ;
JARDINE, L ;
LUKE, B ;
MASSICOTTE, P ;
SILVA, M .
BLOOD, 1994, 83 (05) :1251-1257
[10]   Guidelines for antithrombotic therapy in pediatric patients [J].
Andrew, M ;
Michelson, AD ;
Bovill, E ;
Leaker, M ;
Massicotte, MP .
JOURNAL OF PEDIATRICS, 1998, 132 (04) :575-588